NASDAQ · PAVMW
PAVmed Inc.
Healthcare · Medical - Devices
$0.03
Up+$0.01 (+105.67%)
Updated Sep 19, 2026, 5:56 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 769.75K
- P/E ratio
- -0
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 32.63K
- Avg. volume
- 6.56K
Price performance
PAVMW price history
1M range · 0 trading sessions · Daily adjusted prices
PAVMW does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest PAVMW news
The latest Smart Investors Daily articles mentioning PAVMW.
Stock researchCompany · Overview
PAVMW research
Overview
Company profile and research snapshot.
Company profile
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE). Its product pipeline also comprises EsoGuard, a molecular diagnostic esophageal DNA test; EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo, a disposable infusion platform technology; PortIO, an implantable intraosseous vascular access device; and DisappEAR, a resorbable pediatric ear tube, as well as NextCath and Caldus. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is based in New York, New York.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Nov 5, 2020 | Ascendiant Capital | Buy | — |
| Oct 13, 2020 | Lake Street | Buy | — |
| Jun 28, 2018 | Maxim Group | Buy | — |
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
